Role of Bruton's tyrosine kinase in B cells and malignancies

S Pal Singh, F Dammeijer, RW Hendriks - Molecular cancer, 2018 - Springer
Bruton's tyrosine kinase (BTK) is a non-receptor kinase that plays a crucial role in oncogenic
signaling that is critical for proliferation and survival of leukemic cells in many B cell …

From pathogenesis to treatment of chronic lymphocytic leukaemia

T Zenz, D Mertens, R Küppers, H Döhner… - Nature Reviews …, 2010 - nature.com
Chronic lymphocytic leukaemia (CLL) has several unique features that distinguish it from
other cancers. Most CLL tumour cells are inert and arrested in G0/G1 of the cell cycle and …

Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL

A Agathangelidis, A Chatzidimitriou… - Blood, The Journal …, 2021 - ashpublications.org
Chronic lymphocytic leukemia (CLL) is characterized by the existence of subsets of patients
with (quasi) identical, stereotyped B-cell receptor (BcR) immunoglobulins. Patients in certain …

IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized VJ and VDJ sequence analysis

X Brochet, MP Lefranc, V Giudicelli - Nucleic acids research, 2008 - academic.oup.com
Abstract IMGT/V-QUEST is the highly customized and integrated system for the standardized
analysis of the immunoglobulin (IG) and T cell receptor (TR) rearranged nucleotide …

Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies

A Agathangelidis, N Darzentas… - Blood, The Journal …, 2012 - ashpublications.org
Mounting evidence indicates that grouping of chronic lymphocytic leukemia (CLL) into
distinct subsets with stereotyped BCRs is functionally and prognostically relevant. However …

Recurrent mutations refine prognosis in chronic lymphocytic leukemia

P Baliakas, A Hadzidimitriou, LA Sutton, D Rossi… - Leukemia, 2015 - nature.com
Abstract Through the European Research Initiative on chronic lymphocytic leukemia
(CLL)(ERIC), we screened 3490 patients with CLL for mutations within the NOTCH1 (n …

Cellular origin and pathophysiology of chronic lymphocytic leukemia

M Seifert, L Sellmann, J Bloehdorn, F Wein… - Journal of Experimental …, 2012 - rupress.org
The cellular origin of chronic lymphocytic leukemia (CLL) is still debated, although this
information is critical to understanding its pathogenesis. Transcriptome analyses of CLL and …

T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers

M Palma, G Gentilcore, K Heimersson… - …, 2016 - pmc.ncbi.nlm.nih.gov
Chronic lymphocytic leukemia is characterized by impaired immune functions largely due to
profound T-cell defects. T-cell functions also depend on co-signaling receptors, inhibitory or …

Molecular Subsets of Mantle Cell Lymphoma Defined by the IGHV Mutational Status and SOX11 Expression Have Distinct Biologic and Clinical Features

A Navarro, G Clot, C Royo, P Jares, A Hadzidimitriou… - Cancer research, 2012 - AACR
Mantle cell lymphoma (MCL) is a heterogeneous disease with most patients following an
aggressive clinical course, whereas others having an indolent behavior. We conducted an …

Antigen receptor stereotypy in chronic lymphocytic leukemia

K Stamatopoulos, A Agathangelidis, R Rosenquist… - Leukemia, 2017 - nature.com
The discovery of almost identical or 'stereotyped'B-cell receptor immunoglobulins (BcR IG)
among unrelated patients with chronic lymphocytic leukemia (CLL) cemented the idea of …